It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In the present study, zinc oxide nanoparticles were green-synthesized using the aqueous extract of the rhizomes of Cyperus rotundus. The chemical methods EDX, FE-SEM, XRD, UV-Vis., and FT-IR analysis were used to characterize ZnONPs@C. rotundus were characterized by analytical techniques including. The FE-SEM image revealed a spherical shape for the nanoparticles in a size range of 38.05 to 75.41 nm and 33.09 nm was calculated for ZnONPs@ C. rotundus crystal size using the XRD results. MTT assay was used on common lung well-differentiated bronchogenic adenocarcinoma cell line i.e. HLC-1 to survey the cytotoxicity and anti-lung well-differentiated bronchogenic adenocarcinoma effects of the synthesized nanoparticles. To determine the antioxidant properties of the synthesized nanoparticles, the DPPH test was used in the presence of butylated hydroxytoluene as the positive control. The synthesized nanoparticles had very low cell viability and high anti-lung well-differentiated bronchogenic adenocarcinoma activities dose-dependently against the HLC-1 cell line without any cytotoxicity on the normal cell line (HUVEC). The synthesized nanoparticles inhibited half of the DPPH molecules at the concentration of 41 µg/mL. Maybe significant anti-human lung well-differentiated bronchogenic adenocarcinoma potentials of the synthesized nanoparticles against common human lung well-differentiated bronchogenic adenocarcinoma cell lines are linked to their antioxidant activities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Oncology, The Third People’s Hospital of Hubei Province, Affiliated Hospital of Jianghan University, Wuhan City, Hubei Province, China
2 Department of General Surgery, The First Medical Center for Chinese PLA General Hospital, Beijing, China
3 Department of General Surgery, PLA Marine Corps Hospital, Chaozhou City, China
4 Department of General Surgery, No.215 Hospital of Shaanxi Nuclear Industry, Xianyang City, China